Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Hutter

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Mass Spectrometry : JMS|July 9, 2013
Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolismMelanie Hutter, Bjoern Moosmann, Stefan Kneisel, et al.
Chemical Research in Toxicology|February 3, 2009
Delphinidin modulates the DNA-damaging properties of topoisomerase II poisonsMelanie Esselen, Jessica Fritz, Melanie Hutter, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 28, 2012
Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometryMelanie Hutter, Stefan Kneisel, Volker Auwärter, et al.
Drug Testing and Analysis|May 23, 2013
Acute intoxication by synthetic cannabinoids--four case reportsMaren Hermanns-Clausen, Stefan Kneisel, Melanie Hutter, et al.
Analytical and Bioanalytical Chemistry|August 20, 2013
A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urineMira Sundström, Anna Pelander, Verena Angerer, et al.
Current Pharmaceutical Biotechnology|May 11, 2018
Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MSMelanie Hutter, Sebastian Broecker, Stefan Kneisel, et al.
Journal of Mass Spectrometry : JMS|November 22, 2013
Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokineticsBjoern Moosmann, Laura M Huppertz, Melanie Hutter, et al.
International Journal of Legal Medicine|May 3, 2013
Driving under the influence of synthetic cannabinoids ("Spice"): a case seriesFrank Musshoff, Burkhard Madea, Gerhard Kernbach-Wighton, et al.
Journal of Agricultural and Food Chemistry|May 24, 2011
Anthocyanin-rich blackberry extract suppresses the DNA-damaging properties of topoisomerase I and II poisons in colon carcinoma cellsMelanie Esselen, Ute Boettler, Nicole Teller, et al.
Diabetes, Obesity & Metabolism|May 26, 2017
Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic diseaseKathrin Abegg, Lara Bernasconi, Melanie Hutter, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Mass Spectrometry : JMS|July 9, 2013
Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolismMelanie Hutter, Bjoern Moosmann, Stefan Kneisel, et al.
Chemical Research in Toxicology|February 3, 2009
Delphinidin modulates the DNA-damaging properties of topoisomerase II poisonsMelanie Esselen, Jessica Fritz, Melanie Hutter, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 28, 2012
Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometryMelanie Hutter, Stefan Kneisel, Volker Auwärter, et al.
Drug Testing and Analysis|May 23, 2013
Acute intoxication by synthetic cannabinoids--four case reportsMaren Hermanns-Clausen, Stefan Kneisel, Melanie Hutter, et al.
Analytical and Bioanalytical Chemistry|August 20, 2013
A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urineMira Sundström, Anna Pelander, Verena Angerer, et al.
Current Pharmaceutical Biotechnology|May 11, 2018
Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MSMelanie Hutter, Sebastian Broecker, Stefan Kneisel, et al.
Journal of Mass Spectrometry : JMS|November 22, 2013
Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokineticsBjoern Moosmann, Laura M Huppertz, Melanie Hutter, et al.
International Journal of Legal Medicine|May 3, 2013
Driving under the influence of synthetic cannabinoids ("Spice"): a case seriesFrank Musshoff, Burkhard Madea, Gerhard Kernbach-Wighton, et al.
Journal of Agricultural and Food Chemistry|May 24, 2011
Anthocyanin-rich blackberry extract suppresses the DNA-damaging properties of topoisomerase I and II poisons in colon carcinoma cellsMelanie Esselen, Ute Boettler, Nicole Teller, et al.
Diabetes, Obesity & Metabolism|May 26, 2017
Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic diseaseKathrin Abegg, Lara Bernasconi, Melanie Hutter, et al.
Pageof 2